Graham Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
231,255
+73,280
| +46% | +$53.6K | ﹤0.01% | 1113 |
|
|
2025
Q1 | $127K | Buy |
157,975
+81,675
| +107% | +$65.9K | ﹤0.01% | 1156 |
|
|
2024
Q4 | $105K | Buy |
76,300
+7,649
| +11% | +$10.6K | ﹤0.01% | 1123 |
|
|
2024
Q3 | $71.4K | Buy |
68,651
+33,170
| +93% | +$34.5K | ﹤0.01% | 993 |
|
|
2024
Q2 | $61.4K | Buy |
+35,481
| New | +$61.4K | ﹤0.01% | 951 |
|
|
2023
Q4 | – | Sell |
-131,184
| Closed | -$491K | – | 1014 |
|
|
2023
Q3 | $491K | Buy |
131,184
+2,645
| +2% | +$9.89K | 0.01% | 555 |
|
|
2023
Q2 | $549K | Buy |
+128,539
| New | +$549K | 0.02% | 520 |
|
|
2022
Q4 | – | Sell |
-278,770
| Closed | -$2.68M | – | 1067 |
|
|
2022
Q3 | $2.68M | Buy |
278,770
+83,349
| +43% | +$801K | 0.11% | 141 |
|
|
2022
Q2 | $1.41M | Buy |
195,421
+168,105
| +615% | +$1.22M | 0.06% | 309 |
|
|
2022
Q1 | $352K | Buy |
+27,316
| New | +$352K | 0.01% | 671 |
|